Effects of oral buserelin on urinary LH secretion in male infants

Contraception

Volumn 55, Issue 5, 1997, Pages 311-314

  Bassol, S ^a,b   Barraza Vazquez, A ^a   Nava, M P ^a   Recio, R ^a  

^a University of Coahuila   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE COAHUILA   (Mexico)

Author keywords

Buserelin; Infant; LH; Testosterone

Indexed keywords

BUSERELIN; GONADORELIN DERIVATIVE; LUTEINIZING HORMONE;

ARTICLE; BREAST FEEDING; BREAST MILK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INFANT; LUTEINIZING HORMONE RELEASE; MALE; ORAL DRUG ADMINISTRATION; URINARY EXCRETION;

AGE FACTORS; ANDROGENS; BIOLOGY; BREAST FEEDING; CLINICAL RESEARCH; DEMOGRAPHIC FACTORS; ENDOCRINE SYSTEM; GONADOTROPINS; GONADOTROPINS, PITUITARY; HEALTH; HORMONES; HUMAN MILK; INFANT; INFANT NUTRITION; LACTATION; LUTEINIZING HORMONE; MATERNAL PHYSIOLOGY; NUTRITION; PHYSIOLOGY; POPULATION; POPULATION CHARACTERISTICS; RESEARCH METHODOLOGY; RESEARCH REPORT; TESTOSTERONE; YOUTH;

BREAST FEEDING; BUSERELIN; FEMALE; HUMANS; INFANT; KINETICS; LUTEINIZING HORMONE; MALE; MILK, HUMAN;

EID: 0030843185     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(97)00036-X     Document Type: Article

References (13)

1. Gupta A, Mathur V, Grag SK. Effect of oral contraceptives on quality and quantity of milk secretion in human beings. Indian J Med Res 1974;62:964.
2. Croxato H, Diaz S, et al. Fertility regulation in nursing women. IV. Long-term influence of low-dose combined oral contraceptive initiated at day 30 postpartum upon lactation and infant growth. Contraception 1983;27:13-25.
3. Fraser HM. GnRH analogues for contraception. British Med Bull 1993,49:62-72.
4. Bassol S, Hernandez-Morales C, Trujillo AM, Recio R. Luteinizing hormone-releasing hormone agonist for postpartum contraception. Adv Contracept 1996;12:27-41.
5. Recio R, Barraza-Vazquez A, Recio MG, Fernandez-Gonzalez EM, Bassol M. GnRH agonist for postpartum contraception: biochemical, hormonal and endometrial effects. Adv Contracept 1996;12:15-25.
6. Dewart PJ, McNeilly AS, Smith SK, Sandow J, Hillier SG, Fraser HM. LHRH agonist buserelin as a postpartum contraceptive; lack of biological activity of buserelin in breast milk. Acta Endocrinol (Copenh) 1987;114: 185-92.
7. Kolho KL, Hutaniemi Y. Suppression of pituitary-testis function in rats treated neonatally with a gonadotropin-releasing hormone agonist and antagonist: acute and long-term effects. J Endocrinol 1989;123:83-91.
8. Kolho KL, Hutaniemi Y. Neonatal treatment of male rats with gonadotropin-releasing hormone antagonist results in altered function of the pituitary-testicular axis in adult age. Biol Reprod 1989;41:1084-90.
9. Lunn SF, Recio R, Morris K, Fraser HM. Blockade of the neonatal rise in testosterone by a gonadotrophin-releasing hormone agonist: effects on timing of puberty and sexual behaviour in the male marmoset monkey. J Endocrinol 1994;141:439-47.
10. Mann DR, Gould KG, Collins DC, Wallen K. Blockade of neonatal activation of the pituitary-testicular axis: effect on peripubertal luteinizing hormone and testosterone secretion and on testicular development in male monkeys. J Clin Endocrinol Metab 1989;68:600-7.
11. Liu L, Cristiano AM, et al. Effects of pituitary-testicular axis suppression in utero and during the early neonatal period with a long-acting luteinizing hormine-releasing hormone analog on genital development, somatic growth, and bone density in male cynomologus monkeys in the first 6 months of life. J Clin Endocrinol Metab 1991;73:1038-43.
12. Hutaniemi I, Dunkel L, Perheentupa J. Transient increase in postnatal testicular activity is not revealed by longitudinal measurements of salivary testosterone. Pediat Res 1986;20:1324-7.
13. Sandow J, Fraser HM, Englebart K, Seidel H, Donaubauer H, Rechenberg W. Preclinical studies on suppression of follicular maturation and estrogen secretion in rats and monkeys. In: De K Hoffben, ed. LH-RH Agonist in Oncology. Berlin:Springer-Verlag, 1988:10-9.